PRME Bearish Positioning
Prime Medicine (PRME) is currently exhibiting high levels of short interest, with 27.9% of its float sold short. The stock has been flagged for sustained short pressure, maintaining a 52% short volume ratio over the last five trading days. The days-to-cover ratio stands at 6.3, suggesting that any positive price catalyst could trigger a rapid covering event. Market participants should note that this data reflects a combination of recent flow and established open positions, making it a critical ticker to watch for potential volatility.
Signal data sourced from Tapeboard. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.